PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness.

Vaccine · 2023 · PMC10281226 · PMID 37400286

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Indeed, cancer patients with PD-1/PD-L1 ICB therapy showed a trend towards increased COVID-19 vaccine effectiveness as compared to that of cancer patients with no therapies [5] , [46] .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.